ARRIVENT BIOPHARMA INC. - COMMON STOCK
27.45
22-11月-24 15:44:58
15 分の遅延
株式
+0.86
+3.23%
本日の幅
25.65 - 27.68
ISIN
N/A
ソース
NASDAQ
-
ArriVent BioPharma Reports Third Quarter 2024 Financial Results
14 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
14 8 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
12 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 6 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 5 2024 15:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >